-+ 0.00%
-+ 0.00%
-+ 0.00%

BLOSSOMHILL THERAPEUTICS INC : LEERINK PARTNERS INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $36

Reuters·09/01/2026 11:01:21

Please log in to view news